Table 6 Comparison of important prognostic factors of breast cancer survival rate
From: Predicting factors for survival of breast cancer patients using machine learning techniques
Cluster | VSURF (cut-off VI mean = 0.01) | RandomForestExplainer (First 6 variables) |
|---|---|---|
All data | V11: Tumor size > V9: Cancer stage classification > V22: Total lymph nodes > V23: Positive lymph nodes > V15: Primary treatment type > V6: Method of diagnosis | V11: Tumor size > V9: Cancer stage > V6: Method of diagnosis > V15: Primary treatment type > V22: Total lymph nodes > V23: Positive lymph nodes |
Hormone Receptor Sensitive (HRS) | V9: Cancer stage classification > V11: Tumor size > V22: Total lymph nodes > V15: Primary treatment type > V23: Positive lymph nodes | V11: Tumor size > V9: Cancer stage > V15: Primary treatment type > V23: Positive lymph nodes > V6: Method of diagnosis > V22: Total lymph nodes |
CERB2 Over-expressed | V11: Tumor size > V23: Positive lymph nodes > V9: Cancer stage classification > V22: Total lymph nodes > V15: Primary treatment type | V11: Tumor size > V9: Cancer stage > V15: Primary treatment type > V23: Positive lymph nodes > V6: Method of diagnosis > V22: Total lymph nodes |
Basal/Triple Negative Breast Cancer (TNBC) | V11: Tumor size > V22: Total lymph nodes > V9: Cancer stage classification > V23: Positive lymph nodes> V15: Primary treatment type > V18: Method of axillary lymph node dissection > V17: Type of surgery > V6: Method of diagnosis > V16: Surgery status | V11: Tumor size > V9: Cancer stage > stage > V23: Positive lymph nodes > V22: Total lymph nodes V15: Primary treatment type > V6: Method of diagnosis |